6.13
price up icon0.16%   0.010
pre-market  Vorhandelsmarkt:  6.16   0.03   +0.49%
loading

Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten

pulisher
Jul 29, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Legato Capital Management LLC - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Price Consolidation Hints at Upcoming Move in Amicus Therapeutics Inc.Community Shared Smart Money Signals Show Movement - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Victory Capital Management Inc. Boosts Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 29, 2025
pulisher
Jul 29, 2025

Amicus Therapeutics FOLD 2025Q2 Earnings Preview Upside Potential with Strong Patient Demand Projection - AInvest

Jul 29, 2025
pulisher
Jul 28, 2025

When is Amicus Therapeutics Inc. stock expected to show significant growthDaily Trading Guidance To Watch Now - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Amicus Therapeutics Inc. company’s key revenue driversRapid wealth multiplication - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Amicus Therapeutics Inc. stock overvalued or undervaluedAchieve breakthrough performance in the market - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Amicus Therapeutics Inc. stockAchieve fast wealth growth with smart picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Amicus Therapeutics (FOLD) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Jul 27, 2025
pulisher
Jul 27, 2025

Why is Amicus Therapeutics Inc. stock attracting strong analyst attentionDiscover hidden gems in the stock market - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is it the right time to buy Amicus Therapeutics Inc. stockUnlock expert stock analysis and alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

What makes Amicus Therapeutics Inc. stock price move sharplyROI Driven Alerts - metal.it

Jul 26, 2025
pulisher
Jul 24, 2025

Morgan Stanley Upgrades Amicus (FOLD) on IP Strength and Pipeline Expansion - Insider Monkey

Jul 24, 2025
pulisher
Jul 24, 2025

Amicus Therapeutics Inc. Stock Analysis and ForecastFree AI-Backed Trading Signals - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

How Amicus Therapeutics Inc. stock reacts to Fed policy changesFree Investment Portfolio Suggestions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Amicus Therapeutics Inc. stock priceExceptional profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Edgestream Partners L.P. Takes Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Amicus Therapeutics Inc. stockSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Published on: 2025-07-23 00:04:03 - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Amicus Therapeutics Inc. a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025 - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Amicus Therapeutics Sets Date for Q2 Earnings: Key Updates Expected from Rare Disease Pipeline - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

The Market Doesn't Like What It Sees From Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Revenues Yet - 富途牛牛

Jul 21, 2025
pulisher
Jul 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Stock Rating Upgraded by Morgan Stanley - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap UpWhat's Next? - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Amicus (FOLD) Gets Japan Approval for Pombiliti + Opfolda - MSN

Jul 19, 2025
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Kapitalisierung:     |  Volumen (24h):